Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
ACTON, Mass., May 08, 2018 -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair analysis drug testing, today announced that James Abely has been promoted to the position of Vice President and General Counsel.
In this important role, Jim is responsible for directing and managing all of the company's legal activities, including working closely with the company's clients, and reports directly to the company's CEO. Jim joined Psychemedics in June 2016 as Associate General Counsel, after practicing law for 6 years with the Boston firm of Goodwin Procter LLP, following his graduation from the University of Virginia School of Law. Jim was later promoted to General Counsel.
In making the announcement, Raymond C. Kubacki, Chairman and CEO of Psychemedics, stated "Jim has been an outstanding addition to our team at Psychemedics. In heading up this important area in our company for the past two years, Jim has worked diligently in numerous legal matters and has clearly demonstrated his ability and strong work ethic. He has won the complete confidence of the other members of our management team, as well as our clients. Besides providing our clients with the most vigorous drug test available and outstanding client service, we also extensively support our clients on any legal challenge. We not only provide a litigation packet and expert testimony, but also legal assistance for our clients' legal team to come up to speed quickly. That's why this is such an important role in our company."
Contact:
Raymond C. Kubacki
Chairman, President & CEO
(978) 206-8220
[email protected]
Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.
The Psychemedics web site is www.psychemedics.com
